WBA — Walgreens Boots Alliance Share Price
Last trade - 00:00- $15.40bn
- $27.09bn
- $139.08bn
- 75
- 91
- 38
- 76
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 5.64 | ||
| PEG Ratio (f) | 1.85 | ||
| EPS Growth (f) | 3.15% | ||
| Dividend Yield (f) | 7.71% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.14 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.11 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -21.9% | ||
| Return on Equity | -34.82% | ||
| Operating Margin | -8.98% | ||
Financial Summary
| Year End 31st Aug | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 120,074 | 121,982 | 132,509 | 132,703 | 139,081 | 145,336.9 | 150,927.99 | 1.12% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -8.81 | -45.61 | +3.14 | +128.81 | -60.54 | +14.75 | -3.07 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Walgreens Boots Alliance, Inc. is an integrated healthcare, pharmacy and retailing company. Its segments include U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment includes the Walgreens business, which includes the operations of retail drug stores, health and wellness services, and specialty and home delivery pharmacy services, and its equity method investment in Cencora, Inc. The International segment consists of pharmacy-led health and beauty retail businesses outside the United States and a pharmaceutical wholesaling and distribution business in Germany. The pharmacy-led health and beauty retail businesses include Boots branded stores in the United Kingdom, the Republic of Ireland and Thailand, the Benavides brand in Mexico and the Ahumada brand in Chile. The U.S. Healthcare segment is a consumer-centric, technology-enabled healthcare business that engages consumers through a personalized, omni-channel experience across the care journey.
Directors
- Stefano Pessina CHM (80)
- Rosalind Brewer CEO (59)
- James Kehoe CFO (58)
- Holly May CHO (39)
- Danielle Gray EVP (43)
- John Standley EVP (58)
- Anita Allemand OTH
- Ornella Barra OTH (69)
- William Foote LED (70)
- Steven Shulman DRC (70)
- James Skinner NED (76)
- Janice Babiak IND (63)
- David Brailer IND (62)
- Ginger Graham IND (66)
- Valerie Jarrett IND (65)
- John Lederer IND (66)
- Dominic Murphy IND (54)
- Nancy Schlichting IND (67)
- Last Annual
- August 31st, 2023
- Last Interim
- February 29th, 2024
- Incorporated
- September 2nd, 2014
- Public Since
- December 31st, 2014
- No. of Shareholders
- 43,816
- No. of Employees
- 206,000
- Sector
- Food & Drug Retailing
- Industry
- Consumer Defensives
- Exchange
- NASDAQ Global Select Market
- Shares in Issue
- 862,713,366
- Address
- 108 Wilmot Rd, DEERFIELD, 60015-5145
- Web
- https://www.walgreensbootsalliance.com/
- Phone
- +1 8473152500
- Auditors
- Deloitte & Touche LLP
Latest News for WBA
Upcoming Events for WBA
Q3 2024 Walgreens Boots Alliance Inc Earnings Release
Q4 2024 Walgreens Boots Alliance Inc Earnings Release
Similar to WBA
Caseys General Stores
NASDAQ Global Select Market
Chefs' Warehouse
NASDAQ Global Select Market
Grocery Outlet Holding
NASDAQ Global Select Market
Ingles Markets
NASDAQ Global Select Market
PetMed Express
NASDAQ Global Select Market
FAQ
As of Today at 19:23 UTC, shares in Walgreens Boots Alliance are trading at $17.85. This share price information is delayed by 15 minutes.
Shares in Walgreens Boots Alliance last closed at $17.85 and the price had moved by -50.11% over the past 365 days. In terms of relative price strength the Walgreens Boots Alliance share price has underperformed the S&P500 Index by -59.71% over the past year.
The overall consensus recommendation for Walgreens Boots Alliance is Hold. You can view the full broker recommendation list by unlocking its StockReport.
The Walgreens Boots Alliance dividend yield is 10.76% based on the trailing twelve month period.
Last year, Walgreens Boots Alliance paid a total dividend of $1.92, and it currently has a trailing dividend yield of 10.76%. We do not have any data on when Walgreens Boots Alliance is to next pay dividends.
We do not have data on when Walgreens Boots Alliance is to next pay dividends. The historic dividend yield on Walgreens Boots Alliance shares is currently 10.76%.
To buy shares in Walgreens Boots Alliance you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $17.85, shares in Walgreens Boots Alliance had a market capitalisation of $15.40bn.
Here are the trading details for Walgreens Boots Alliance:
- Country of listing: United States
- Exchange: NSQ
- Ticker Symbol: WBA
Based on an overall assessment of its quality, value and momentum Walgreens Boots Alliance is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Walgreens Boots Alliance is $23.27. That is 30.36% above the last closing price of $17.85.
Analysts covering Walgreens Boots Alliance currently have a consensus Earnings Per Share (EPS) forecast of $3.23 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Walgreens Boots Alliance. Over the past six months, its share price has underperformed the S&P500 Index by -34.46%.
As of the last closing price of $17.85, shares in Walgreens Boots Alliance were trading -24.23% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Walgreens Boots Alliance PE ratio based on its reported earnings over the past 12 months is 5.64. The shares last closed at $17.85.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Walgreens Boots Alliance's management team is headed by:
- Stefano Pessina - CHM
- Rosalind Brewer - CEO
- James Kehoe - CFO
- Holly May - CHO
- Danielle Gray - EVP
- John Standley - EVP
- Anita Allemand - OTH
- Ornella Barra - OTH
- William Foote - LED
- Steven Shulman - DRC
- James Skinner - NED
- Janice Babiak - IND
- David Brailer - IND
- Ginger Graham - IND
- Valerie Jarrett - IND
- John Lederer - IND
- Dominic Murphy - IND
- Nancy Schlichting - IND